Stay updated on NICHE: Clinical Trial on IO in Early Colon Cancer
Sign up to get notified when there's something new on the NICHE: Clinical Trial on IO in Early Colon Cancer page.

Latest updates to the NICHE: Clinical Trial on IO in Early Colon Cancer page
- Check6 days agoChange DetectedThis reflects a minor ClinicalTrials.gov frontend/system revision update, changing the displayed version marker without modifying the study details shown on the page.SummaryDifference0.0%

- Check13 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check42 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check56 days agoChange DetectedAccrual for cohort 8 was reached in February 2026. As of February 2026, only cohorts 5 and 7 remain open for recruitment, and patients with dMMR/MSI tumors will be automatically registered in cohort 7 to receive nivolumab + relatlimab.SummaryDifference0.3%

- Check77 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed. This represents a minor version update with no changes to study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check85 days agoChange DetectedAdded Revision: v3.4.1 and removed Revision: v3.4.0 to reflect the latest site update.SummaryDifference0.0%

Stay in the know with updates to NICHE: Clinical Trial on IO in Early Colon Cancer
Enter your email address, and we'll notify you when there's something new on the NICHE: Clinical Trial on IO in Early Colon Cancer page.